Literature DB >> 23060928

Effect of Jagged1 on the proliferation and migration of colon cancer cells.

Yong Tan1, Jingjing Peng, Dong Wei, Peng Chen, Yu Zhao.   

Abstract

The aim of this study was to determine the effect of Jagged1 on the proliferation and migration of colon cancer cells. HT-29 colorectal carcinoma cells were transfected with adenovirus carrying either the Jagged1 gene (Ad-Jagged1) or Jagged1 small interfering RNA (siRNA) (Ad-si/hJagged1). The protein was detected using western blot analysis. The proliferation of cells was observed by assessing the incorporation of [(3)H]-thymidine. The migration of cells was detected using a modified Boyden chamber assay. The level of Jagged1 protein increased by 2.8-fold with Ad-Jagged1 transfection and decreased by 70% with Ad-si/hJagged1 transfection. Proliferation, migration and p-Akt protein expression were enhanced in the Ad-Jagged1-transfected group compared to that in the non-transfected control group. In addition, the proliferation, migration and phosphorylated Akt protein expression were reduced in the Ad-si/hJagged1-transfected group compared to that in the non-transfected control group. The Jagged1 protein may promote proliferation and migration of colon cancer cells, which may be related to its effect on Akt phosphorylation.

Entities:  

Year:  2012        PMID: 23060928      PMCID: PMC3460292          DOI: 10.3892/etm.2012.549

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  9 in total

Review 1.  Cancer epidemiology in the last century and the next decade.

Authors:  J Peto
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase.

Authors:  Marcella Priulla; Angela Calastretti; Paola Bruno; Amalia Azzariti; Azzariti Amalia; Angelo Paradiso; Gianfranco Canti; Angelo Nicolin
Journal:  Prostate       Date:  2007-05-15       Impact factor: 4.104

3.  Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38.

Authors:  Céline Gongora; Laurent Candeil; Nadia Vezzio; Virginie Copois; Vincent Denis; Corinne Breil; Franck Molina; Caroline Fraslon; Emmanuel Conseiller; Bernard Pau; Pierre Martineau; Maguy Del Rio
Journal:  Cancer Biol Ther       Date:  2008-03-04       Impact factor: 4.742

Review 4.  Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts.

Authors:  Julie A Wickenden; Christine J Watson
Journal:  Breast Cancer Res       Date:  2010-04-09       Impact factor: 6.466

5.  Oscillations in notch signaling regulate maintenance of neural progenitors.

Authors:  Hiromi Shimojo; Toshiyuki Ohtsuka; Ryoichiro Kageyama
Journal:  Neuron       Date:  2008-04-10       Impact factor: 17.173

Review 6.  Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.

Authors:  Dexin Zhang; Daiming Fan
Journal:  Expert Rev Anticancer Ther       Date:  2007-10       Impact factor: 4.512

7.  Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.

Authors:  Z Shafaee; H Schmidt; W Du; M Posner; R Weichselbaum
Journal:  Cancer Chemother Pharmacol       Date:  2006-03-22       Impact factor: 3.333

8.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

Review 9.  Mammary stem cells and breast cancer--role of Notch signalling.

Authors:  Gillian Farnie; Robert B Clarke
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.